TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
BDSX

Biodesix Inc

Healthcare · Diagnostics & Research

29.10$ -4.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Biodesix Inc (BDSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 95 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BDSX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
87 99 87 116 103 97 86 88 89 87 95 95
29 40 28 58 44 39 30 32 33 33 41 44
20 26 11 42 31 26 18 21 17 19 26 30
20 26 11 42 31 26 18 21 17 19 26 30
5.8 7.7 9.9 10 8.0 8.6 7.6 7.5 13 9.0 9.5 9.2
1.3 1.4 1.4 1.2 1.2 – – – 1.4 – – –
15 15 15 15 15 15 15 15 15 15 15 15
8.4 7.9 7.4 6.9 6.4 5.9 5.4 4.9 4.4 3.9 3.5 3.0
88 95 93 80 75 76 75 87 90 90 86 86
33 33 31 18 13 14 13 15 18 17 14 15
1.2 0.3 0.3 0.3 0.7 0.7 1.1 1.2 1.4 1.4 1.5 1.6
2.9 2.9 3.2 2.2 2.5 2.2 2.9 3.0 3.6 3.1 3.7 2.2
25 35 36 36 36 36 37 47 47 47 46 47
-1.4 4.6 -5.5 36 28 21 11 1.1 -1.7 -2.5 9.1 9.1
-410 -420 -433 -444 -454 -462 -474 -485 -494 -498 -506 -513
4.0 4.6 4.9 6.4 7.3 7.3 7.3 7.3 7.5 8.1 9.7 10

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?